INIMMUNE CORP
Federal contract awards won by INIMMUNE CORP (UEI EF8AMXMGG8W5), 2020–2023 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
4
awards
0
expiring in 12 months
1
agency
Teaming snapshot
teams under 4 primes.
From subcontract reports primes file with USAspending/FSRS.
Where their reported work happens
| State | Reported subawards |
|---|---|
| MT | 5 |
Place of performance on subcontract reports filed with USAspending/FSRS.
Category award history
2 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: THE EMMES COMPANY, LLC took Department of Health and Human Services 541715 work from INIMMUNE CORP (May 31, 2023).
Agencies buying from INIMMUNE CORP
What INIMMUNE CORP has provided
Awards
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
Department of Health and Human Services · $7,776,786 · Sep 30, 2023
SBIR TOPIC 091 PHASE II: DEVELOPMENT OF A NEW TLR4 AGONIST FOR THE TREATMENT OF ALLERGIC RHINITIS
Department of Health and Human Services · $1,836,453 · Sep 1, 2021
ADJUVANT DISCOVERY FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASES
Department of Health and Human Services · $598,808 · Sep 1, 2021
PRODUCTION OF SYNTHETIC ADJUVANT SYSTEM (SAS): A SYNERGISTIC COMBINATION OF SYNTHETIC ADJUVANT COMPONENTS
Department of Health and Human Services · $1,992,471 · Jun 1, 2020